Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019

被引：0

作者：

Samaratunga, Hemamali ^{[1
,2
]}

Delahunt, Brett ^{[3
]}

Egevad, Lars ^{[4
]}

机构：

[1] Univ Queensland, Brisbane, Qld, Australia

[2] Aquesta Uropathol, Brisbane, Qld, Australia

[3] Univ Otago, Wellington Sch Med & Hlth Sci, Wellington, New Zealand

[4] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

来源：

EUROPEAN UROLOGY | 2022年 / 82卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2022.03.032

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E15 / E16

页数：2

共 28 条

[21] Re: Isabel Rauscher, Charlotte Duwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for 68Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018; 73:656-61 Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists
Cimadamore, Alessia
Scarpelli, Marina
Cheng, Liang
Lopez-Beltran, Antonio
Montorsi, Francesco
Montironi, Rodolfo
[J]. EUROPEAN UROLOGY, 2018, 74 (06) : E141 - E144
[22] Reply to Stephen B. Williams and John F. Ward's Letter to the Editor re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052
Hadaschik, Boris A.
Radtke, Jan Philipp
[J]. EUROPEAN UROLOGY, 2016, 70 (03) : E79 - E80
[23] Reply to Anwar R. Padhani, Frederic LeCouvet, Giuseppe Petralia, and Dow-Mu Koh's Letter to the Editor re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2024.02.016
Garcia-Ruiz, Alonso
Macarro, Carlos
Mateo, Joaquin
Perez-Lopez, Raquel
[J]. EUROPEAN UROLOGY, 2024, 86 (03) : e69 - e70
[24] Reply to Ferhat Ates, Ilker Akyol and Hasan Soydan's Letter to the Editor re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results from a Prospective Observational Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002
Bul, Meelan
Zhu, Xiaoye
Roobol, Monique J.
[J]. EUROPEAN UROLOGY, 2012, 62 (01) : E10 - E11
[25] Re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging- Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j. euf.2023.04.008
Gravina, Carmen
Lombardo, Riccardo
De Nunzio, Cosimo
[J]. EUROPEAN UROLOGY FOCUS, 2024, 10 (01): : 206 - 207
[26] Reply to Ozan Cem Guler and Cem Onal's Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and ce:sup>18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate- specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005
Pan, Jian
Wang, Beihe
Zhu, Yao
[J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (04): : 479 - 479
[27] Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Becker, Russell E. N.
Baras, Alex
Bivalacqua, Trinity J.
[J]. EUROPEAN UROLOGY, 2021, 79 (02) : E58 - E59
[28] Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 68 Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.11.008
Guidotti, Alessio
Lombardo, Riccardo
De Nunzio, Cosimo
[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 1156 - 1157

← 1 2 3 →